Using an agar dilution assay, for 66 of 104 (63.5%) clinical isolates of Acinetobacter calcoaceticus biovar anitratus, the MIC of ciprofloxacin was .1.0 ,ug/ml. Cross resistance was demonstrable to ciprofloxacin and gentamicin (P < 0.001), amikacin (P < 0.01), cefotaxime (P < 0.001), azlocillin (P < 0.001), ceftazidime (P < 0.001), trinethoprim-sulfamethoxazole (P < 0.001), and minocycline (P < 0.05). The mean MIC of ciprofloxacin for drug-susceptible isolates was consistently lower than that for resistant isolates; however, these differences were significant only for amikacin (P = 0.036).
Acinetobacter calcoaceticus biovar anitratus has emerged in recent years as an important cause of nosocomial infection. Most isolates are resistant to multiple antimicrobial drugs, including newer 3-lactam antibiotics (3, 7, 8) . Several reports indicate that multiply resistant isolates are susceptible to carboxyquinolones (1, 5, 8) .
In the present study, we determined the antimicrobial susceptibility of Acinetobacter strains isolated in two 500-bed general hospitals during the years 1986 and 1987. MICs were determined by agar dilution and disk diffusion methods, and these data were correlated with susceptibility to eight antimicrobial agents commonly employed for the treatment of nosocomial infection.
A total of 104 isolates of A. calcoaceticus biovar anitratus (one isolate from each patient) were obtained from blood, cerebrospinal fluid, urine, sputum, and wounds. Bacteria were identified by standard methods (9 the strains tested and for 90% of the strains tested were 0.5 to 1.0 and 2 ,ug/ml, respectively. Of 104 strains, 38 (36.5%) were susceptible to ciprofloxacin concentrations of below 1.0 ,ug/ml. The mean MIC of ciprofloxacin for drug-susceptible isolates was consistently lower than that for resistant isolates (Fig. 1) ; however, the difference between susceptible and resistant strains was significant only for amikacin (P = 0.036).
Correlations between susceptibility of Acinetobacter isolates to ciprofloxacin and eight other antimicrobial agents are further analyzed in Table 1 . Resistance to aminoglycosides, P-lactams, and trimethoprim-sulfamethoxazole was significantly more common among isolates for which the MIC of ciprofloxacin was 21 jig/ml. This trend was still demonstrable (P < 0.05) for ceftazidime, cefotaxime, amikacin, and sulfamethoxazole-trimethoprim when data were analyzed for strains for which the MIC of ciprofloxacin was .2 ,ug/ml.
Our findings indicate that multiply resistant Acinetobacter strains isolated from patients with nosocomial infections are generally susceptible to ciprofloxacin. Among the aminoglycosides, only amikacin may be considered as a suitable drug for empiric therapy (71.1% susceptible strains). Indeed, a prior study demonstrated that gentamicin-resistant strains of "Acinetobacter anitratus" have diminished susceptibility to norfloxacin and ciprofloxacin (11) .
Minocycline also exhibited good in vitro activity (84.6% susceptible). Ceftazidime was the most active (61.5% susceptible) of the P-lactams tested, while cefotaxime and azlocillin were not effective. Others have found that transfer of Acinetobacter species in broth containing P-lactam antibiotics may promote quinolone resistance (6) . Susceptibility to imipenem is diminished only slightly among transferred and quinolone-resistant isolates (6, 8, 11) .
Previous studies have demonstrated an association between resistance of Klebsiella and Serratia isolates to trimethoprim, chloramphenicol, and nalidixic acid. Concomitant P-lactam and quinolone resistance in Klebsiella pneumoniae has been described (4) . In such cases, outer membrane changes were demonstrated in resistant bacteria, suggesting the existence of a permeability barrier (10) . Whether a similar mechanism may be operative for A. calcoaceticus biovar anitratus is unknown and warrants further investigation. 
